Literature DB >> 18787792

Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.

Kyeo-Re Lee1, Eun-Jung Kim, Sang-Wan Seo, Hoo-Kyun Choi.   

Abstract

The effects of poloxamer and HPMC on the dissolution rate of felodipine were investigated and a felodipine controlled release tablet was developed by increasing the water solubility of felodipine and using swelling polymer to control release rate. Milling of felodipine slightly increased the dissolution rate of felodipine when compared with physical mixture. XRD results indicated that felodipine remained in the crystalline form even after co-milling with poloxamer. Improved dissolution rates after co-milling with HPMC and poloxamer were due to both solubilization effect of polymer and milling. The effect of poloxamer on dissolution rate was more significant than that of HPMC. Based on increased solubility of felodipine in the presence of poloxamer, it was concluded that the improved dissolution rate of felodipine was mainly due to a high local concentration of poloxamer around felodipine. Controlled release felodipine tablets were prepared using poloxamer as a solubilizing agent and Carbopol as a controlled release matrix.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787792     DOI: 10.1007/s12272-001-1263-9

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Production and stability evaluation of modified-release microparticles for the delivery of drug combinations.

Authors:  Muhammad Naeem Aamir; Mahmood Ahmad
Journal:  AAPS PharmSciTech       Date:  2010-03-10       Impact factor: 3.246

2.  Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis.

Authors:  Goldi Kaul; Jun Huang; Ramarao Chatlapalli; Krishnendu Ghosh; Arwinder Nagi
Journal:  AAPS PharmSciTech       Date:  2011-08-23       Impact factor: 3.246

3.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

4.  Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement.

Authors:  Anam Saleem; Naveed Akhtar; Muhammad Usman Minhas; Arshad Mahmood; Kifayat Ullah Khan; Orva Abdullah
Journal:  Gels       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.